Beacon Financial Group Bristol Myers Squibb CO Transaction History

Beacon Financial Group

  • $869 Million
  • Q2 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$47.98 - $54.4 $2.78 Million - $3.15 Million
-57,980 Reduced 92.52%
4,685 $254,000
Q4 2023

Feb 23, 2024
SELL
$48.48 - $57.85 $104,522 - $124,724
-2,156 Reduced 3.33%
62,665 $3.22 Million
Q3 2023

Oct 16, 2023
SELL
$57.89 - $64.73 $34,618 - $38,708
-598 Reduced 0.91%
64,821 $4 Million
Q2 2023

Jul 20, 2023
SELL
$63.71 - $70.74 $33,638 - $37,350
-528 Reduced 0.8%
65,419 $4.19 Million
Q1 2023

Apr 14, 2023
SELL
$65.71 - $74.53 $157,572 - $178,722
-2,398 Reduced 3.51%
65,947 $4.64 Million
Q4 2022

Jan 19, 2023
SELL
$68.48 - $81.09 $44,101 - $52,221
-644 Reduced 0.93%
68,345 $4.92 Million
Q3 2022

Oct 13, 2022
SELL
$0.13 - $76.84 $57 - $33,732
-439 Reduced 0.63%
68,989 $4.95 Million
Q2 2022

Jul 19, 2022
SELL
$72.62 - $79.98 $49,308 - $54,306
-679 Reduced 0.97%
69,428 $5.46 Million
Q1 2022

Apr 08, 2022
BUY
$61.48 - $73.72 $29,756 - $35,680
484 Added 0.7%
70,107 $5.14 Million
Q4 2021

Jan 07, 2022
SELL
$53.63 - $62.52 $36,897 - $43,013
-688 Reduced 0.98%
69,623 $4.31 Million
Q3 2021

Oct 13, 2021
BUY
$59.17 - $69.31 $2.82 Million - $3.31 Million
47,728 Added 211.34%
70,311 $4.26 Million
Q2 2021

Jul 26, 2021
SELL
$61.91 - $67.42 $2.9 Million - $3.15 Million
-46,779 Reduced 67.44%
22,583 $4.7 Million
Q4 2020

Jan 15, 2021
BUY
$57.74 - $65.43 $15,127 - $17,142
262 Added 0.38%
69,362 $4.57 Million
Q3 2020

Oct 13, 2020
SELL
$57.43 - $63.64 $73,338 - $81,268
-1,277 Reduced 1.81%
69,100 $4.17 Million
Q2 2020

Aug 05, 2020
BUY
$54.82 - $64.09 $32,508 - $38,005
593 Added 0.85%
70,377 $4.07 Million
Q1 2020

Jun 29, 2020
BUY
$46.4 - $67.43 $85,700 - $124,543
1,847 Added 2.72%
69,784 $3.8 Million
Q4 2019

Jan 17, 2020
SELL
$49.21 - $64.19 $262,781 - $342,774
-5,340 Reduced 7.29%
67,937 $3.93 Million
Q2 2019

Jul 15, 2019
SELL
$44.62 - $49.34 $265,622 - $293,721
-5,953 Reduced 7.51%
73,277 $3.5 Million
Q1 2019

Apr 18, 2019
SELL
$45.12 - $53.8 $248,250 - $296,007
-5,502 Reduced 6.49%
79,230 $3.7 Million
Q4 2018

Jan 16, 2019
SELL
$48.76 - $63.23 $208,985 - $271,003
-4,286 Reduced 4.81%
84,732 $3.22 Million
Q3 2018

Oct 10, 2018
SELL
$55.19 - $62.25 $74,506 - $84,037
-1,350 Reduced 1.49%
89,018 $3.96 Million
Q2 2018

Jul 11, 2018
SELL
$50.53 - $62.98 $104,900 - $130,746
-2,076 Reduced 2.25%
90,368 $3.66 Million
Q1 2018

Apr 06, 2018
SELL
$59.92 - $68.98 $128,887 - $148,375
-2,151 Reduced 2.27%
92,444 $3.61 Million
Q4 2017

Jan 03, 2018
SELL
$59.94 - $65.35 $113,466 - $123,707
-1,893 Reduced 1.96%
94,595 $4.12 Million
Q3 2017

Oct 03, 2017
BUY
$55.23 - $63.74 $5.33 Million - $6.15 Million
96,488
96,488 $3.99 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Beacon Financial Group Portfolio

Follow Beacon Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email